"Yet, NASA will face a myriad of daunting budgetary, industrial, geopolitical, technical, and health and medical constraints and challenges," the report continues, "as it both executes the Artemis ...

And Artemis 3, a crewed moon landing that had been targeted for late 2026, is now scheduled for mid-2027. The extra time is needed primarily to finish prepping the Orion capsule for its first-ever ...

It's scheduled to launch in April 2026. Artemis 3 will put humans down on the moon's surface for the first time since Apollo 17 in 1972. It's now scheduled for mid-2027.

Ixo-vec is a potential best-in-class one-time gene therapy designed to deliver long-term efficacy, reduce the burden of frequent anti-VEGF and ...

the Artemis 3 mission is oversubscribed." As it has in the past, the ASAP views the aggregated risk associated with accomplishing "so many 'first-time' milestones, including several critical ...